Literature DB >> 20819969

Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.

Stephanie J Frisbee1, Anoop Shankar, Sarah S Knox, Kyle Steenland, David A Savitz, Tony Fletcher, Alan M Ducatman.   

Abstract

BACKGROUND: Perfluorooctanoic acid (PFOA) and perfluorooctanesulfonate (PFOS) are man-made compounds with widespread presence in human sera. In previous occupational and adult studies, PFOA and PFOS were positively associated with serum lipid levels.
OBJECTIVE: To interrogate associations between PFOA and PFOS and serum lipids in children and adolescents.
DESIGN: Cross-sectional community-based study.
SETTING: Mid-Ohio River Valley. PARTICIPANTS: A total of 12 476 children and adolescents included in the C8 Health Project, which resulted from the pretrial settlement of a class action lawsuit pursuant to PFOA contamination of the drinking water supply. MAIN OUTCOME MEASURES: Serum lipids (total, high-density lipoprotein [HDL-C], and low-density lipoprotein [LDL-C] cholesterol and fasting triglycerides).
RESULTS: Mean (SD) serum PFOA and PFOS concentrations were 69.2 (111.9) ng/mL and 22.7 (12.6) ng/mL, respectively. In linear regression after adjustment for covariables, PFOA was significantly associated with increased total cholesterol and LDL-C, and PFOS was significantly associated with increased total cholesterol, HDL-C, and LDL-C. Using general linear model analysis of covariance, between the first and fifth quintiles of PFOA there was a 4.6-mg/dL and a 3.8-mg/dL increase in the adjusted mean levels of total cholesterol and LDL-C levels, respectively, and an 8.5-mg/dL and a 5.8-mg/dL increase in the adjusted mean levels of total cholesterol and LDL-C, respectively, between the first and fifth quintiles of PFOS. Increases were 10 mg/dL for some age- and sex-group strata. Observed effects were nonlinear, with larger increases in total cholesterol and LDL-C levels occurring at the lowest range, particularly of PFOA.
CONCLUSION: Although the epidemiologic and cross-sectional natures of this study limit causal inferences, the consistently observed associations between increasing PFOA and PFOS and elevated total cholesterol and LDL-C levels warrant further study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819969      PMCID: PMC3116641          DOI: 10.1001/archpediatrics.2010.163

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  20 in total

1.  Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters.

Authors:  Edward Anthony Emmett; Hong Zhang; Frances Susan Shofer; David Freeman; Nancy Virginia Rodway; Chintan Desai; Leslie Michael Shaw
Journal:  J Occup Environ Med       Date:  2006-08       Impact factor: 2.162

2.  Quantitative determination of perfluorooctanoic acid in serum and plasma by liquid chromatography tandem mass spectrometry.

Authors:  John M Flaherty; Paul D Connolly; Emily R Decker; S Mark Kennedy; Mark E Ellefson; William K Reagen; Bogdan Szostek
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-05-25       Impact factor: 3.205

3.  Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources.

Authors:  Edward Anthony Emmett; Frances Susan Shofer; Hong Zhang; David Freeman; Chintan Desai; Leslie Michael Shaw
Journal:  J Occup Environ Med       Date:  2006-08       Impact factor: 2.162

4.  Perfluorooctanoic acid, a peroxisome-proliferating hypolipidemic agent, dissociates apolipoprotein B48 from lipoprotein particles and decreases secretion of very low density lipoproteins by cultured rat hepatocytes.

Authors:  E Okochi; T Nishimaki-Mogami; K Suzuki; A Takahashi
Journal:  Biochim Biophys Acta       Date:  1999-03-25

5.  Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species.

Authors:  S G Hundley; A M Sarrif; G L Kennedy
Journal:  Drug Chem Toxicol       Date:  2006       Impact factor: 3.356

Review 6.  The toxicology of perfluorooctanoate.

Authors:  Gerald L Kennedy; John L Butenhoff; Geary W Olsen; John C O'Connor; Andrew M Seacat; Roger G Perkins; Lisa B Biegel; Sandra R Murphy; David G Farrar
Journal:  Crit Rev Toxicol       Date:  2004 Jul-Aug       Impact factor: 5.635

Review 7.  PPARalpha agonist-induced rodent tumors: modes of action and human relevance.

Authors:  James E Klaunig; Michael A Babich; Karl P Baetcke; Jon C Cook; J Chris Corton; Raymond M David; John G DeLuca; David Y Lai; Richard H McKee; Jeffrey M Peters; Ruth A Roberts; Penelope A Fenner-Crisp
Journal:  Crit Rev Toxicol       Date:  2003       Impact factor: 5.635

Review 8.  Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.

Authors:  Naomi Kudo; Yoichi Kawashima
Journal:  J Toxicol Sci       Date:  2003-05       Impact factor: 2.196

9.  Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy.

Authors:  Koichi Inoue; Fumio Okada; Rie Ito; Shizue Kato; Seiko Sasaki; Sonomi Nakajima; Akiko Uno; Yasuaki Saijo; Fumihiro Sata; Yoshihiro Yoshimura; Reiko Kishi; Hiroyuki Nakazawa
Journal:  Environ Health Perspect       Date:  2004-08       Impact factor: 9.031

10.  The C8 health project: design, methods, and participants.

Authors:  Stephanie J Frisbee; A Paul Brooks; Arthur Maher; Patsy Flensborg; Susan Arnold; Tony Fletcher; Kyle Steenland; Anoop Shankar; Sarah S Knox; Cecil Pollard; Joel A Halverson; Verónica M Vieira; Chuanfang Jin; Kevin M Leyden; Alan M Ducatman
Journal:  Environ Health Perspect       Date:  2009-07-13       Impact factor: 9.031

View more
  75 in total

1.  Metabolomics of childhood exposure to perfluoroalkyl substances: a cross-sectional study.

Authors:  Samantha L Kingsley; Douglas I Walker; Antonia M Calafat; Aimin Chen; George D Papandonatos; Yingying Xu; Dean P Jones; Bruce P Lanphear; Kurt D Pennell; Joseph M Braun
Journal:  Metabolomics       Date:  2019-06-21       Impact factor: 4.290

2.  Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid.

Authors:  Lobna M Eldasher; Xia Wen; Michael S Little; Kristin M Bircsak; Lindsay L Yacovino; Lauren M Aleksunes
Journal:  Toxicology       Date:  2013-02-19       Impact factor: 4.221

3.  Demographic, Reproductive, and Dietary Determinants of Perfluorooctane Sulfonic (PFOS) and Perfluorooctanoic Acid (PFOA) Concentrations in Human Colostrum.

Authors:  Todd A Jusko; Marina Oktapodas; L'ubica Palkovičová Murinová; Katarina Babinská; Jana Babjaková; Marc-André Verner; Jamie C DeWitt; Kelly Thevenet-Morrison; Kamil Čonka; Beata Drobná; Jana Chovancová; Sally W Thurston; B Paige Lawrence; Ann M Dozier; Kirsi M Järvinen; Henrieta Patayová; Tomáš Trnovec; Juliette Legler; Irva Hertz-Picciotto; Marja H Lamoree
Journal:  Environ Sci Technol       Date:  2016-06-14       Impact factor: 9.028

4.  Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Abby F Fleisch; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2019-05-28       Impact factor: 9.621

5.  High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring.

Authors:  Youngja H Park; Kichun Lee; Quinlyn A Soltow; Frederick H Strobel; Kenneth L Brigham; Richard E Parker; Mark E Wilson; Roy L Sutliff; Keith G Mansfield; Lynn M Wachtman; Thomas R Ziegler; Dean P Jones
Journal:  Toxicology       Date:  2012-03-01       Impact factor: 4.221

6.  Sociodemographic and behavioral determinants of serum concentrations of per- and polyfluoroalkyl substances in a community highly exposed to aqueous film-forming foam contaminants in drinking water.

Authors:  Kelsey E Barton; Anne P Starling; Christopher P Higgins; Carrie A McDonough; Antonia M Calafat; John L Adgate
Journal:  Int J Hyg Environ Health       Date:  2019-08-20       Impact factor: 5.840

7.  Evaluation of a national data set for insights into sources, composition, and concentrations of per- and polyfluoroalkyl substances (PFASs) in U.S. drinking water.

Authors:  Jennifer L Guelfo; David T Adamson
Journal:  Environ Pollut       Date:  2018-05       Impact factor: 8.071

8.  Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population.

Authors:  Kim E Innes; Alan M Ducatman; Michael I Luster; Anoop Shankar
Journal:  Am J Epidemiol       Date:  2011-06-27       Impact factor: 4.897

Review 9.  Recent developments in polyfluoroalkyl compounds research: a focus on human/environmental health impact, suggested substitutes and removal strategies.

Authors:  John Baptist Nzukizi Mudumbi; Seteno Karabo Obed Ntwampe; Tandi Matsha; Lukhanyo Mekuto; Elie Fereche Itoba-Tombo
Journal:  Environ Monit Assess       Date:  2017-07-18       Impact factor: 2.513

Review 10.  Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).

Authors:  Kyle Steenland; Tony Fletcher; David A Savitz
Journal:  Environ Health Perspect       Date:  2010-04-27       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.